Navigation Links
Betting on Change - The Venture Forum in 2008

SANTA CLARA, Calif., May 14 /PRNewswire/ -- Shining a spotlight on the ever-growing field of life sciences, Larta Institute's 14th Annual Venture Forum will provide a ray of hope in the midst of the dark backdrop of the current economy. This year the Forum has the unparalleled opportunity to focus on brilliant entrepreneurs in the life sciences, even while concerns are surfacing on broader economic issues. "For 14 years, through good economic times and bad, the passion and ingenuity of entrepreneurs has been an inspiration for us all," says Rohit Shukla, CEO of Larta Institute. Therefore, Larta's focus on market-ready and well-coached seed-stage companies from across the globe attracts the most experienced, insightful and driven industry leaders to this "marketplace of ideas and solutions."

"Financing for innovation is always challenging, especially when the world economy is dealing with inflation, deflation, high energy prices, economic downturn and credit market crises," said G. Steven Burrill, CEO of Burrill & Company, and a featured keynote speaker. "The Venture Forum brings together innovation and capital in a creative atmosphere -- this kind of financing is the hallmark of an innovative society." Burrill & Company is co-producing the event with Larta Institute. The other noteworthy keynote speakers this year, including Boris Nikolic of the Gates Foundation and Mary Woolley, president of Research!America, and a host of seasoned industry executives, will describe and embrace the advancements, opportunities and pitfalls of this critical sector.

The Venture Forum is the culmination of Larta's close mentoring of showcased innovators over the course of many months, and as such is considered the premier platform for emerging companies to present and exhibit for serious investors and industry executives. "Larta's Venture Forum offers an exciting opportunity to view compelling emerging technology innovations -- this fits well with P&G Health Care's objectives, which are focused on external discovery to fill our pipeline," said Bruce Halpryn of Procter & Gamble Health Care. "The ideas being pitched at the Forum are of great interest to us in our continuing search for innovative technologies that could drive new business opportunities for P&G Health Care."

In this "rich brew of innovation," as Shukla refers to it, presenting companies are specially selected from the National Institutes of Health's Commercialization Assistance Program, managed by Larta institute. In addition, an equal number are selected from Larta's network, representing 36 states, 12 universities and entrepreneurs from Larta's Global Bridge network, this year featuring Brazil and Canada.

Larta Institute's track record of success ensures that this year's event will once again present great new business opportunities not seen on the regular conference circuit.

2008 Life Sciences Venture Forum, Friday, May 30 -- Santa Clara Convention Center:

Attendee Registration:

Credentialed Media: To register for press passes, contact Avi Kulokas at or 213-538-1451.

Sponsorship Opportunities: For information on sponsorship, contact Carlos Gutierrez at or 213-538-1453.

For information about Larta Institute, visit


Constanza Pachon

Tel. 213/538-1451


This release was issued through eReleases(TM). For more information, visit

SOURCE Larta Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
2. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
3. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
4. 3 strikes, youre out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause
5. Atrium Innovations Announces Management Changes
6. Genmab Announces Asset Exchange Agreement
7. Biomira announces plan to change name to Oncothyreon
8. Ardea Biosciences Announces Changes to Research Management
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
11. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
Post Your Comments:
(Date:11/27/2015)... /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), a ... closed the sale of its global contrast media and ... in a transaction valued at approximately $270 million. The ... total of approximately 1,000 employees spread across the globe, ... area. This entire workforce and the manufacturing ...
(Date:11/25/2015)... PUNE, India , November 26, 2015 /PRNewswire/ ... The Global Biobanking Market 2016 - 2020 ... biobanks by maintaining integrity and quality in long-term ... and enabling long-term cost-effectiveness. Automation minimizes manual errors ... improves the technical efficiency. Further, it plays a ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Neurocrine ... Kevin Gorman , President and CEO of Neurocrine ... Jaffray Healthcare Conference in New York ... encouraged to visit the website approximately 5 minutes prior ... software.  A replay of the presentation will be available ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
Breaking Biology Technology:
(Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
(Date:11/9/2015)... , Nov. 09, 2015 ... the addition of the "Global Law ... their offering. --> ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):